Search company, investor...
SEQENS company logo


Founded Year



Acq - Fin - IV | Alive




SEQENS specializes in pharmaceutical synthesis and specialty ingredients. It develops tailor-made solutions and ingredients for various industries, including healthcare, electronics, cosmetics, food, and home care. The company was founded in 2003 and is based in Ecully, France.

Headquarters Location

21, Chemin de la Sauvegarde

Ecully, 69130,


Missing: SEQENS's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SEQENS's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

SEQENS Frequently Asked Questions (FAQ)

  • When was SEQENS founded?

    SEQENS was founded in 2003.

  • Where is SEQENS's headquarters?

    SEQENS's headquarters is located at 21, Chemin de la Sauvegarde, Ecully.

  • What is SEQENS's latest funding round?

    SEQENS's latest funding round is Acq - Fin - IV.

  • Who are the investors of SEQENS?

    Investors of SEQENS include SK Capital Partners, Merieux Developpement, Eurazeo, Ardian and Bain Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.